Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Clinical and Biological Consequences of Levothyrox® Formula Modification

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Thyroid disorder treated by Levothyroxine~* Age over 18 year old~* TSH plasma level within the 12 months before formulation modification~* TSH plasma level within the 6 months after formulation modification~Exclusion Criteria:~- Thyroid dysfunction (hypo or hyperthyroidism) despite Levothyroxine treatment, ie TSH plasma level out of normal range within the 6 months before formula modification

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).